Blood and lymphatic cancer : targets and therapy Journal

Overview

publication venue for

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.. 10. 2020

Identity

ISO Abbreviation

Blood Lymphat Cancer

Linking ISSN

1179-9889

Electronic International Standard Serial Number (EISSN)

1179-9889